WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (243)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostrerova, N.
Right arrow Articles by Wolozin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostrerova, N.
Right arrow Articles by Wolozin, B.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 15, 1999, 19(14):5782-5791

alpha -Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

Natalie Ostrerova1, Leonard Petrucelli1, Matthew Farrer2, Nitinkumar Mehta2, Peter Choi1, John Hardy2, and Benjamin Wolozin1

1 Department of Pharmacology, Loyola University Medical Center, Maywood, Illinois 60153, and 2 Department of Pharmacology, Mayo Clinic, Jacksonville, Florida 32224

alpha -Synuclein has been implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease. Mutations in alpha -synuclein cause some cases of familial PD (Polymeropoulos et al., 1997; Kruger et al., 1998). In addition, many neurodegenerative diseases show accumulation of alpha -synuclein in dystrophic neurites and in Lewy bodies (Spillantini et al., 1998). Here, we show that alpha -synuclein shares physical and functional homology with 14-3-3 proteins, which are a family of ubiquitous cytoplasmic chaperones. Regions of alpha -synuclein and 14-3-3 proteins share over 40% homology. In addition, alpha -synuclein binds to 14-3-3 proteins, as well as some proteins known to associate with 14-3-3, including protein kinase C, BAD, and extracellular regulated kinase, but not Raf-1. We also show that overexpression of alpha -synuclein inhibits protein kinase C activity. The association of alpha -synuclein with BAD and inhibition of protein kinase C suggests that increased expression of alpha -synuclein could be harmful. Consistent with this hypothesis, we observed that overexpression of wild-type alpha -synuclein is toxic, and overexpression of alpha -synuclein containing the A53T or A30P mutations exhibits even greater toxicity. The activity and binding profile of alpha -synuclein suggests that it might act as a protein chaperone and that accumulation of alpha -synuclein could contribute to cell death in neurodegenerative diseases.

Key words: 14-3-3 proteins; Alzheimer's disease; apoptosis; BAD; extracellular regulated kinase; Parkinson's disease; protein kinase C; synuclein


Copyright © 1999 Society for Neuroscience  0270-6474/99/19145782-10$05.00/0


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. A. Cartier, L. A. Parra, T. B. Baust, M. Quiroz, G. Salazar, V. Faundez, L. Egana, and G. E. Torres
A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles
J. Biol. Chem., January 15, 2010; 285(3): 1957 - 1966.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, H. Lou, C. J. Pedersen, A. D. Smith, and R. G. Perez
14-3-3{zeta} Contributes to Tyrosine Hydroxylase Activity in MN9D Cells: LOCALIZATION OF DOPAMINE REGULATORY PROTEINS TO MITOCHONDRIA
J. Biol. Chem., May 22, 2009; 284(21): 14011 - 14019.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Bisaglia, S. Mammi, and L. Bubacco
Structural insights on physiological functions and pathological effects of {alpha}-synuclein
FASEB J, February 1, 2009; 23(2): 329 - 340.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. A. McFarland, C. E. Ellis, S. P. Markey, and R. L. Nussbaum
Proteomics Analysis Identifies Phosphorylation-dependent {alpha}-Synuclein Protein Interactions
Mol. Cell. Proteomics, November 1, 2008; 7(11): 2123 - 2137.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. E. Paleologou, A. W. Schmid, C. C. Rospigliosi, H.-Y. Kim, G. R. Lamberto, R. A. Fredenburg, P. T. Lansbury Jr., C. O. Fernandez, D. Eliezer, M. Zweckstetter, et al.
Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of {alpha}-Synuclein
J. Biol. Chem., June 13, 2008; 283(24): 16895 - 16905.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. A. El-Agnaf
{gamma}-Synuclein and the progression of cancer
FASEB J, November 1, 2007; 21(13): 3419 - 3430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Nelson and D. L. Alkon
Protection against beta-Amyloid-induced Apoptosis by Peptides Interacting with beta-Amyloid
J. Biol. Chem., October 26, 2007; 282(43): 31238 - 31249.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. C. Stichel, X.-R. Zhu, V. Bader, B. Linnartz, S. Schmidt, and H. Lubbert
Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage
Hum. Mol. Genet., October 15, 2007; 16(20): 2377 - 2393.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
V. Limviphuvadh, S. Tanaka, S. Goto, K. Ueda, and M. Kanehisa
The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs)
Bioinformatics, August 15, 2007; 23(16): 2129 - 2138.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Zhang, A. Kanthasamy, Y. Yang, V. Anantharam, and A. Kanthasamy
Protein Kinase C{delta} Negatively Regulates Tyrosine Hydroxylase Activity and Dopamine Synthesis by Enhancing Protein Phosphatase-2A Activity in Dopaminergic Neurons
J. Neurosci., May 16, 2007; 27(20): 5349 - 5362.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Periquet, T. Fulga, L. Myllykangas, M. G. Schlossmacher, and M. B. Feany
Aggregated {alpha}-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo
J. Neurosci., March 21, 2007; 27(12): 3338 - 3346.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fujita, S. Sugama, M. Nakai, T. Takenouchi, J. Wei, T. Urano, S. Inoue, and M. Hashimoto
{alpha}-Synuclein Stimulates Differentiation of Osteosarcoma Cells: RELEVANCE TO DOWN-REGULATION OF PROTEASOME ACTIVITY
J. Biol. Chem., February 23, 2007; 282(8): 5736 - 5748.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. R. Mazzulli, A. J. Mishizen, B. I. Giasson, D. R. Lynch, S. A. Thomas, A. Nakashima, T. Nagatsu, A. Ota, and H. Ischiropoulos
Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates
J. Neurosci., September 27, 2006; 26(39): 10068 - 10078.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Leng and D.-M. Chuang
Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
J. Neurosci., July 12, 2006; 26(28): 7502 - 7512.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Chalovich, J.-h. Zhu, J. Caltagarone, R. Bowser, and C. T. Chu
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
J. Biol. Chem., June 30, 2006; 281(26): 17870 - 17881.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Avraham, R. Szargel, A. Eyal, R. Rott, and S. Engelender
Glycogen Synthase Kinase 3beta Modulates Synphilin-1 Ubiquitylation and Cellular Inclusion Formation by SIAH: IMPLICATIONS FOR PROTEASOMAL FUNCTION AND LEWY BODY FORMATION
J. Biol. Chem., December 30, 2005; 280(52): 42877 - 42886.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C. M. P. Rodrigues, A. Alfonso, C. Steer, et al.
Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of {alpha}-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans
J. Biol. Chem., December 30, 2005; 280(52): 42655 - 42668.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
W. W. Smith, H. Jiang, Z. Pei, Y. Tanaka, H. Morita, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity
Hum. Mol. Genet., December 15, 2005; 14(24): 3801 - 3811.
[Abstract] [Full Text] [PDF]


Home page
Integr. Comp. Biol.Home page
K. Goyal, L. J. Walton, J. A. Browne, A. M. Burnell, and A. Tunnacliffe
Molecular Anhydrobiology: Identifying Molecules Implicated in Invertebrate Anhydrobiosis
Integr. Comp. Biol., November 1, 2005; 45(5): 702 - 709.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. Bridges and G. B. G. Moorhead
14-3-3 Proteins: A Number of Functions for a Numbered Protein
Sci. Signal., August 9, 2005; 2005(296): re10 - re10.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
X. M. Peng, R. Tehranian, P. Dietrich, L. Stefanis, and R. G. Perez
{alpha}-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells
J. Cell Sci., August 1, 2005; 118(15): 3523 - 3530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean
The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways
J. Biol. Chem., June 24, 2005; 280(25): 23727 - 23734.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. R. Jimenez, F. J. Stam, K. W. Li, Y. Gouwenberg, M. P. Hornshaw, F. De Winter, J. Verhaagen, and A. B. Smit
Proteomics of the Injured Rat Sciatic Nerve Reveals Protein Expression Dynamics During Regeneration
Mol. Cell. Proteomics, February 1, 2005; 4(2): 120 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Rideout, P. Dietrich, Q. Wang, W. T. Dauer, and L. Stefanis
{alpha}-Synuclein Is Required for the Fibrillar Nature of Ubiquitinated Inclusions Induced by Proteasomal Inhibition in Primary Neurons
J. Biol. Chem., November 5, 2004; 279(45): 46915 - 46920.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Chandra, F. Fornai, H.-B. Kwon, U. Yazdani, D. Atasoy, X. Liu, R. E. Hammer, G. Battaglia, D. C. German, P. E. Castillo, et al.
Double-knockout mice for {alpha}- and {beta}-synucleins: Effect on synaptic functions
PNAS, October 12, 2004; 101(41): 14966 - 14971.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhou, G. Gu, D. R. Goodlett, T. Zhang, C. Pan, T. J. Montine, K. S. Montine, R. H. Aebersold, and J. Zhang
Analysis of {alpha}-Synuclein-associated Proteins by Quantitative Proteomics
J. Biol. Chem., September 10, 2004; 279(37): 39155 - 39164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-i. Satoh, T. Yamamura, and K. Arima
The 14-3-3 Protein {epsilon} Isoform Expressed in Reactive Astrocytes in Demyelinating Lesions of Multiple Sclerosis Binds to Vimentin and Glial Fibrillary Acidic Protein in Cultured Human Astrocytes
Am. J. Pathol., August 1, 2004; 165(2): 577 - 592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hashimoto, P. Bar-on, G. Ho, T. Takenouchi, E. Rockenstein, L. Crews, and E. Masliah
{beta}-Synuclein Regulates Akt Activity in Neuronal Cells: A POSSIBLE MECHANISM FOR NEUROPROTECTION IN PARKINSON'S DISEASE
J. Biol. Chem., May 28, 2004; 279(22): 23622 - 23629.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. A. Wilson, D. D. Murphy, B. I. Giasson, B. Zhang, J. Q. Trojanowski, and V. M.-Y. Lee
Degradative organelles containing mislocalized {alpha}- and {beta}-synuclein proliferate in presenilin-1 null neurons
J. Cell Biol., May 10, 2004; 165(3): 335 - 346.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. K. Dougherty and D. K. Morrison
Unlocking the code of 14-3-3
J. Cell Sci., April 15, 2004; 117(10): 1875 - 1884.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. RECCHIA, P. DEBETTO, A. NEGRO, D. GUIDOLIN, S. D. SKAPER, and P. GIUSTI
{alpha}-Synuclein and Parkinson's disease
FASEB J, April 1, 2004; 18(6): 617 - 626.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. SIDHU, C. WERSINGER, and P. VERNIER
Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse?
FASEB J, April 1, 2004; 18(6): 637 - 647.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Ninkina, K. Papachroni, D. C. Robertson, O. Schmidt, L. Delaney, F. O'Neill, F. Court, A. Rosenthal, S. M. Fleetwood-Walker, A. M. Davies, et al.
Neurons Expressing the Highest Levels of {gamma}-Synuclein Are Unaffected by Targeted Inactivation of the Gene
Mol. Cell. Biol., November 15, 2003; 23(22): 8233 - 8245.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies
Hum. Mol. Genet., October 16, 2003; 12(20): 2625 - 2635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Martinez, I. Moeller, H. Erdjument-Bromage, P. Tempst, and B. Lauring
Parkinson's Disease-associated alpha -Synuclein Is a Calmodulin Substrate
J. Biol. Chem., May 2, 2003; 278(19): 17379 - 17387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Snyder, K. Mensah, C. Theisler, J. Lee, A. Matouschek, and B. Wolozin
Aggregated and Monomeric alpha -Synuclein Bind to the S6' Proteasomal Protein and Inhibit Proteasomal Function
J. Biol. Chem., March 28, 2003; 278(14): 11753 - 11759.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Kirik, L. E. Annett, C. Burger, N. Muzyczka, R. J. Mandel, and A. Bjorklund
Nigrostriatal alpha -synucleinopathy induced by viral vector-mediated overexpression of human alpha -synuclein: A new primate model of Parkinson's disease
PNAS, March 4, 2003; 100(5): 2884 - 2889.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Dou, W. J. Netzer, K. Tanemura, F. Li, F. U. Hartl, A. Takashima, G. K. Gouras, P. Greengard, and H. Xu
Chaperones increase association of tau protein with microtubules
PNAS, January 21, 2003; 100(2): 721 - 726.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
O. CHIBA-FALEK and R.L. NUSSBAUM
Regulation of {alpha}-Synuclein Expression: Implications for Parkinson's Disease
Cold Spring Harb Symp Quant Biol, January 1, 2003; 68(0): 409 - 416.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
N. Gosavi, H.-J. Lee, J. S. Lee, S. Patel, and S.-J. Lee
Golgi Fragmentation Occurs in the Cells with Prefibrillar alpha -Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion
J. Biol. Chem., December 6, 2002; 277(50): 48984 - 48992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-H. Zhu, S. M. Kulich, T. D. Oury, and C. T. Chu
Cytoplasmic Aggregates of Phosphorylated Extracellular Signal-Regulated Protein Kinases in Lewy Body Diseases
Am. J. Pathol., December 1, 2002; 161(6): 2087 - 2098.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Lotharius and P. Brundin
Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Park, H. Y. Jung, H. O. Kim, H. Rhim, S. R. Paik, K. C. Chung, J. H. Park, and J. Kim
Evidence that alpha -synuclein functions as a negative regulator of Ca++-dependent alpha -granule release from human platelets
Blood, September 18, 2002; 100(7): 2506 - 2514.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-Z. Pan, W. Bruening, B. I. Giasson, V. M.-Y. Lee, and A. K. Godwin
gamma -Synuclein Promotes Cancer Cell Survival and Inhibits Stress- and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways
J. Biol. Chem., September 13, 2002; 277(38): 35050 - 35060.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Park, H. Y. Jung, T. D. Kim, J. H. Park, C.-H. Yang, and J. Kim
Distinct Roles of the N-terminal-binding Domain and the C-terminal-solubilizing Domain of alpha -Synuclein, a Molecular Chaperone
J. Biol. Chem., August 2, 2002; 277(32): 28512 - 28520.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. G. Perez, J. C. Waymire, E. Lin, J. J. Liu, F. Guo, and M. J. Zigmond
A Role for alpha -Synuclein in the Regulation of Dopamine Biosynthesis
J. Neurosci., April 15, 2002; 22(8): 3090 - 3099.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T. E. Johansen, N. Muzyczka, R. J. Mandel, and A. Bjorklund
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of alpha -Synuclein in the Nigrostriatal System
J. Neurosci., April 1, 2002; 22(7): 2780 - 2791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-H. Ahn, H. Rhim, S. Y. Kim, Y.-M. Sung, M.-Y. Lee, J.-Y. Choi, B. Wolozin, J.-S. Chang, Y. H. Lee, T. K. Kwon, et al.
alpha -Synuclein Interacts with Phospholipase D Isozymes and Inhibits Pervanadate-induced Phospholipase D Activation in Human Embryonic Kidney-293 Cells
J. Biol. Chem., March 29, 2002; 277(14): 12334 - 12342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. B. Cole, D. D. Murphy, T. Grider, S. Rueter, D. Brasaemle, and R. L. Nussbaum
Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein alpha -Synuclein
J. Biol. Chem., February 15, 2002; 277(8): 6344 - 6352.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
B. Wolozin and N. Golts
Book Review: Iron and Parkinson's Disease
Neuroscientist, February 1, 2002; 8(1): 22 - 32.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
L. Stefanis, K. E. Larsen, H. J. Rideout, D. Sulzer, and L. A. Greene
Expression of A53T Mutant But Not Wild-Type alpha -Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death
J. Neurosci., December 15, 2001; 21(24): 9549 - 9560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D J Burn and E Jaros
Multiple system atrophy: cellular and molecular pathology
Mol. Pathol., December 1, 2001; 54(6): 419 - 426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bussell Jr. and D. Eliezer
Residual Structure and Dynamics in Parkinson's Disease-associated Mutants of alpha -Synuclein
J. Biol. Chem., November 30, 2001; 276(49): 45996 - 46003.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Waelter, A. Boeddrich, R. Lurz, E. Scherzinger, G. Lueder, H. Lehrach, and E. E. Wanker
Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation
Mol. Biol. Cell, May 1, 2001; 12(5): 1393 - 1407.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
Y. Tanaka, S. Engelender, S. Igarashi, R. K. Rao, T. Wanner, R. E. Tanzi, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross
Inducible expression of mutant {{alpha}}-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
Hum. Mol. Genet., April 1, 2001; 10(9): 919 - 926.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. J. S. LEE, F. LIU, Z. B. PRISTUPA, and H. B. NIZNIK
Direct binding and functional coupling of {alpha}-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
FASEB J, April 1, 2001; 15(6): 916 - 926.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. J. Tabrizi, M. Orth, J. M. Wilkinson, J.-W. Taanman, T. T. Warner, J. M. Cooper, and A. H.V. Schapira
Expression of mutant {alpha}-synuclein causes increased susceptibility to dopamine toxicity
Hum. Mol. Genet., November 1, 2000; 9(18): 2683 - 2689.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, A. Schindzielorz, M. Okochi, U. Leimer, H. van der Putten, A. Probst, et al.
Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant alpha -Synuclein in Human and Transgenic Mouse Brain
J. Neurosci., September 1, 2000; 20(17): 6365 - 6373.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Ostrerova-Golts, L. Petrucelli, J. Hardy, J. M. Lee, M. Farer, and B. Wolozin
The A53T alpha -Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
J. Neurosci., August 15, 2000; 20(16): 6048 - 6054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, M. Mallory, J. Wong, T. Takenouchi, M. Hashimoto, and E. Masliah
{alpha}-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Am. J. Pathol., August 1, 2000; 157(2): 401 - 410.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. Wolozin and C. Behl
Mechanisms of Neurodegenerative Disorders: Part 1: Protein Aggregates
Arch Neurol, June 1, 2000; 57(6): 793 - 796.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. da Costa, K. Ancolio, and F. Checler
Wild-type but Not Parkinson's Disease-related Ala-53 right-arrow Thr Mutant alpha -Synuclein Protects Neuronal Cells from Apoptotic Stimuli
J. Biol. Chem., July 28, 2000; 275(31): 24065 - 24069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. N. Pronin, A. J. Morris, A. Surguchov, and J. L. Benovic
Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases
J. Biol. Chem., August 18, 2000; 275(34): 26515 - 26522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hashiguchi, K. Sobue, and H. K. Paudel
14-3-3zeta Is an Effector of Tau Protein Phosphorylation
J. Biol. Chem., August 11, 2000; 275(33): 25247 - 25254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Jeanclos, L. Lin, M. W. Treuil, J. Rao, M. A. DeCoster, and R. Anand
The Chaperone Protein 14-3-3eta Interacts with the Nicotinic Acetylcholine Receptor alpha 4 Subunit. EVIDENCE FOR A DYNAMIC ROLE IN SUBUNIT STABILIZATION
J. Biol. Chem., July 20, 2001; 276(30): 28281 - 28290.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Nielsen, H. Vorum, E. Lindersson, and P. H. Jensen
Ca2+ Binding to alpha -Synuclein Regulates Ligand Binding and Oligomerization
J. Biol. Chem., June 15, 2001; 276(25): 22680 - 22684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Iwata, M. Maruyama, I. Kanazawa, and N. Nukina
alpha -Synuclein Affects the MAPK Pathway and Accelerates Cell Death
J. Biol. Chem., November 21, 2001; 276(48): 45320 - 45329.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2010 by Society for Neuroscience ONLINE ISSN: 1529-2401
-